Search research articles
Contact Us
Filters
Showing results (1-10 of 139) with videos related to
Page
of 14
Sort By:
Soins; La Revue De Reference Infirmiere
|
May 30, 2009
[Chronicity of HIV infections, a persistent evolution]
Isabelle Poizot-Martin
Bulletin Du Cancer
|
January 13, 2015
[Cancer and HIV]
Jean-Philippe Spano, Isabelle Poizot-Martin, Laurent Quero
International Journal of STD & AIDS
|
April 13, 2019
Unsupervised PrEP in routine practice: a new challenge?
Hélène Laroche, Caroline Lions, Olivia Zaegel-Faucher, et al.
Bulletin Du Cancer
|
November 25, 2014
[HIV-related malignancies: state of art]
Aurélien Gobert, Nicolas Mounier, Armelle Lavole, et al.
Bulletin Du Cancer
|
January 26, 2020
[HIV and cancer: Update 2020]
Baptiste Abbar, Marianne Veyri, Caroline Solas, et al.
European Journal of Gastroenterology & Hepatology
|
April 26, 2016
From first-generation hepatitis C virus protease inhibitors to direct-acting antivirals: self-reported symptoms as a warning signal for potential adverse events (ANRS HC26, ANRS HC27 trials)
Fabienne Marcellin, Isabelle Fournier, Maria P Carrieri, et al.
American Journal of Clinical Oncology
|
February 2, 2002
Phase IV study of liposomal daunorubicin (DaunoXome) in AIDS-related Kaposi sarcoma
Eric Rosenthal, Isabelle Poizot-Martin, Thierry Saint-Marc, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology
|
August 26, 2006
Coexistence of the K65R/L74V and/or K65R/T215Y mutations on the same HIV-1 genome
Mireille Henry, Christian Tourres, Philippe Colson, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology
|
July 2, 2013
Relapse of hepatitis C virus after 14 months of sustained virological response following pegylated-interferon alpha plus ribavirin therapy in a human immunodeficiency virus type 1 infected patient
Philippe Colson, Sylvie Bregigeon, Christian Tourres, et al.
Antiviral Therapy
|
February 15, 2017
Impact of tenofovir dose adjustment on both estimated glomerular filtration rate and tenofovir trough concentration
Sylvie Bregigeon, Caroline Solas, Olivia Faucher, et al.
Page
of 14
Search research articles
Search
Showing results (1-10 of 139) with videos related to
Sort By:
Page
of 14
Soins; La Revue De Reference Infirmiere
|
May 30, 2009
[Chronicity of HIV infections, a persistent evolution]
Isabelle Poizot-Martin
Bulletin Du Cancer
|
January 13, 2015
[Cancer and HIV]
Jean-Philippe Spano, Isabelle Poizot-Martin, Laurent Quero
International Journal of STD & AIDS
|
April 13, 2019
Unsupervised PrEP in routine practice: a new challenge?
Hélène Laroche, Caroline Lions, Olivia Zaegel-Faucher, et al.
Bulletin Du Cancer
|
November 25, 2014
[HIV-related malignancies: state of art]
Aurélien Gobert, Nicolas Mounier, Armelle Lavole, et al.
Bulletin Du Cancer
|
January 26, 2020
[HIV and cancer: Update 2020]
Baptiste Abbar, Marianne Veyri, Caroline Solas, et al.
European Journal of Gastroenterology & Hepatology
|
April 26, 2016
From first-generation hepatitis C virus protease inhibitors to direct-acting antivirals: self-reported symptoms as a warning signal for potential adverse events (ANRS HC26, ANRS HC27 trials)
Fabienne Marcellin, Isabelle Fournier, Maria P Carrieri, et al.
American Journal of Clinical Oncology
|
February 2, 2002
Phase IV study of liposomal daunorubicin (DaunoXome) in AIDS-related Kaposi sarcoma
Eric Rosenthal, Isabelle Poizot-Martin, Thierry Saint-Marc, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology
|
August 26, 2006
Coexistence of the K65R/L74V and/or K65R/T215Y mutations on the same HIV-1 genome
Mireille Henry, Christian Tourres, Philippe Colson, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology
|
July 2, 2013
Relapse of hepatitis C virus after 14 months of sustained virological response following pegylated-interferon alpha plus ribavirin therapy in a human immunodeficiency virus type 1 infected patient
Philippe Colson, Sylvie Bregigeon, Christian Tourres, et al.
Antiviral Therapy
|
February 15, 2017
Impact of tenofovir dose adjustment on both estimated glomerular filtration rate and tenofovir trough concentration
Sylvie Bregigeon, Caroline Solas, Olivia Faucher, et al.
Page
of 14